Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -409.85% is 59% below its 1-year average of -257.76%, near the low end of its 1-year range (-409.85%–-105.68%).
As of the fiscal period ended Wednesday, December 31, 2025. 59.00% below its 12-month average of -257.76%.
Limited history available
PBLS Return on Invested Capital (ROIC) has fewer than three reported periods, so a trend chart would be misleading.
RETURN ON INVESTED CAPITAL (ROIC)
-409.85%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-257.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-59.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-1049.33%
vs the sector median at left
Parabilis Medicines, Inc.
Market Cap
$3.36B
Return on Invested Capital (ROIC)
-409.85%
TTM Avg
-257.76%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.38B
Return on Invested Capital (ROIC)
6.25%
TTM Avg
16.80%
3Y Avg
-7.33%
5Y Avg
-16.60%
Market Cap
$3.31B
Return on Invested Capital (ROIC)
-135.85%
TTM Avg
-39.34%
3Y Avg
-38.88%
5Y Avg
-33.43%
Market Cap
$3.30B
Return on Invested Capital (ROIC)
-0.93%
TTM Avg
1.17%
3Y Avg
-16.63%
5Y Avg
-13.35%
Market Cap
$3.44B
Return on Invested Capital (ROIC)
-79.40%
TTM Avg
-65.84%
3Y Avg
-73.62%
5Y Avg
-96.54%
Market Cap
$3.47B
Return on Invested Capital (ROIC)
-28.15%
TTM Avg
-46.92%
3Y Avg
-38.64%
5Y Avg
-44.96%
Market Cap
$3.48B
Return on Invested Capital (ROIC)
-17.68%
TTM Avg
-22.74%
3Y Avg
-21.16%
5Y Avg
-18.86%
Market Cap
$3.52B
Return on Invested Capital (ROIC)
-1.07%
TTM Avg
-9.16%
3Y Avg
-22.10%
5Y Avg
-20.63%
Market Cap
$3.54B
Return on Invested Capital (ROIC)
-35.27%
TTM Avg
-38.13%
3Y Avg
-29.19%
5Y Avg
-24.81%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Parabilis Medicines, Inc. (PBLS) | $3.36B | -409.85% | -257.76% | N/A | N/A |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 6.25% | 16.80% | -7.33% | -16.60% |
| Viking Therapeutics, Inc. (VKTX)vs › | $3.31B | -135.85% | -39.34% | -38.88% | -33.43% |
| CareDx, Inc (CDNA)vs › | $3.30B | -0.93% | 1.17% | -16.63% | -13.35% |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | -79.40% | -65.84% | -73.62% | -96.54% |
| Celcuity Inc. (CELC)vs › | $3.47B | -28.15% | -46.92% | -38.64% | -44.96% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | -17.68% | -22.74% | -21.16% | -18.86% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | -1.07% | -9.16% | -22.10% | -20.63% |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.54B | -35.27% | -38.13% | -29.19% | -24.81% |
| Tarsus Pharmaceuticals, Inc. (TARS)vs › | $3.19B | -11.15% | -28.66% | -37.37% | -28.82% |
ROIC
-409.9%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | -409.85% |
| 2024-12-31 | -105.68% |
